Abeona Therapeutics Stock Forecast

Stock Price Forecast

According to 7 analysts polled by S&P Global, Abeona Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $19.71. The average 1-year stock price forecast is 241.59% higher than the current stock price, while the lowest is $14 (+142.63%) and the highest is $28 (+385.27%).

Price Target: $19.71 (+241.59%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$14	$19.71	$20	$28
Change	+142.63%	+241.59%	+246.62%	+385.27%

Analyst Ratings

The average analyst rating for Abeona Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	May '26
Strong Buy	6	6	6	6	6	6
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	6	6	6	6	6	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Ram Selvaraju H.C. Wainwright	H.C. Wainwright	Buy Reiterates $15 → $20	Buy	Reiterates	$15 → $20	+246.62%	May 28, 2026
Unknown Analyst Jefferies No rating	Jefferies	Buy Maintains $17	Buy	Maintains	$17	+194.63%	May 14, 2026
Unknown Analyst Oppenheimer No rating	Oppenheimer	Buy Reiterates $22	Buy	Reiterates	$22	+281.28%	May 14, 2026
James Molloy Alliance Global Partners	Alliance Global Partners	Buy Reiterates $20	Buy	Reiterates	$20	+246.62%	May 13, 2026
Stephen Willey Stifel Nicolaus	Stifel Nicolaus	Buy Maintains $17	Buy	Maintains	$17	+194.63%	Mar 19, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

65.51M

from 5.82M

1,025.58%

from 5.82M

Revenue Next Year

134.94M

from 65.51M

105.99%

from 65.51M

EPS This Year

-0.68

from -1.24

EPS Next Year

0.29

from -0.68

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	3.00M	1.41M	3.50M	-	5.82M	65.51M
Revenue Growth	-70.00%	-52.87%	147.53%	-	-	1,025.58%
Gross Profit	-35.73M	-28.00M	-29.20M	-34.36M	-24.42M	45.86M
Gross Margin	-1,190.87%	-1,980.27%	-834.17%	-	-419.54%	70.00%
Operating Income	-57.37M	-45.26M	-48.20M	-64.21M	-89.45M	-51.07M
Net Income	-84.94M	-39.70M	-54.19M	-63.73M	71.18M	-42.25M
EPS	-	-	-	-	-1.24	-0.68
Free Cash Flow	-62.58M	-19.73M	-18.89M	-37.88M	-55.60M	-44.00M
No. Analysts	-	-	-	-	-	6

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	87.1M
Avg	65.5M
Low	50.3M

Revenue Growth

Revenue Growth	2026	2027	2028
High	1,396.0%
Avg	1,025.6%
Low	764.3%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-0.68
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-